Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017
This table browses all dspace content
Issue DateTitleJournal Title
2023Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinomaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2023Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2023CD4/CD8 Ratio Recovery Among People Living With HIV Starting With First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort AnalysisJAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2023INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) BMC CANCER
2023Low skeletal muscle mass is associated with mortality in kidney transplant recipientsAMERICAN JOURNAL OF TRANSPLANTATION
2023Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study JOURNAL OF CLINICAL ONCOLOGY
2023Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma CANCER IMMUNOLOGY IMMUNOTHERAPY
2023A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation CANCER
2023Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes : Long-Term Outcomes From the CONFIRM RegistryHEART LUNG AND CIRCULATION
2023Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer NATURE COMMUNICATIONS
2023Preface CLINICAL AND MOLECULAR HEPATOLOGY
2023Diabetes, Atherosclerosis, and Stenosis by AI DIABETES CARE
2023Reply: The Clinical Outcomes and Success of Posterior Wall Isolation Using a "Box" Approach JACC. Clinical Electrophysiology
2023Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future CLINICAL AND MOLECULAR HEPATOLOGY
2023Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes FRONTIERS IN ENDOCRINOLOGY
2023Evaluation of an air quality warning system for vulnerable and susceptible individuals in Korea: an interrupted time series analysis EPIDEMIOLOGY AND HEALTH
2023The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosusKIDNEY INTERNATIONAL
2023The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension Clinical Hypertension
2023Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal Cancer: A Prospective, Randomised Phase II Study Stratified by O6-Methylguanine DNA Methyltransferase Status: KCSG-CO17-02CLINICAL ONCOLOGY
2023자가면역간염의 치료 Korean Journal of Gastroenterology

Browse

Links